1-20 of 1124 Search Results for

Medicare Part D

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Article
J Health Polit Policy Law (2022) 47 (6): 853–877.
Published: 01 December 2022
...Erin Trish; Katrina M. Kaiser; Jeanai Celestin; Geoffrey Joyce Abstract Context: Reforming the Medicare Part D program—which provides prescription drug coverage to 49 million beneficiaries—has emerged as a key policy priority. Methods: The authors evaluate prescription drug claims from a 100...
FIGURES | View All (8)
Journal Article
J Health Polit Policy Law (2021) 46 (6): 1053–1068.
Published: 01 December 2021
..., the Trump administration failed to implement any of their more ambitious reform ideas. This article considers three of the Trump administration's signature policies—state-sponsored prescription drug importation, Medicare Part B international reference pricing, and reforms to the Medicare Part D rebate...
Journal Article
J Health Polit Policy Law (2011) 36 (6): 961–973.
Published: 01 December 2011
...-provided health insurance, and the Medicare Part D prescription drug program — demonstrate how policy designs affect subsequent policy outcomes. To differing degrees, the three cases show how public policies can create constituencies with particular understandings of their benefits who attempt to thwart...
Journal Article
J Health Polit Policy Law (2021) 46 (4): 599–609.
Published: 01 August 2021
... whether the government should establish a Medicare prescription drug benefit with legal authority to negotiate drug prices (Cubanski et al. 2019 ). Instead, prescription drug coverage in Medicare Part D was offered exclusively through commercial health insurance plans with a promise that the secretary...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 709–729.
Published: 01 December 2022
... policy in ensuring access to pharmacotherapies, whether through promotion of generic and biosimilar entry via patent policy reform (Grabowski, DiMasi, and Long 2015 ) and legislation preserving competition in markets or through more aggressive, direct regulation such as Medicare Part D price negotiation...
FIGURES
Journal Article
J Health Polit Policy Law (2014) 39 (1): 209–235.
Published: 01 February 2014
...., a drug plan that covers their prescriptions). Findings provide hints of what government can do to support competition in such markets. We first examine the Medicare program, which has three markets where beneficiaries choose among health insurance plans: Part C, the Medicare Advantage program; Part D...
Journal Article
J Health Polit Policy Law (2010) 35 (6): 961–997.
Published: 01 December 2010
... benefit that best serves the needs of Medicare beneficiaries. © 2011 by Duke University Press 2011 References Abaluck J. T. Gruber J. . 2009 . Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program . Working paper 14759 . February...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 755–778.
Published: 01 December 2022
..., so the price cap would be national. Medicare Advantage and Part D drug plans retain authority to negotiate additional discounts. HHS would negotiate prices for 25 or more drugs a year, up to a total of 250 (Sachs 2019 ). The BBBA and IRA anchor Medicare's negotiated prices for 10 to 15 drugs...
FIGURES
Journal Article
J Health Polit Policy Law (2011) 36 (3): 387–391.
Published: 01 June 2011
...Kimberly J. Morgan; Andrea Louise Campbell © 2011 by Duke University Press 2011 References Abaluck J. T. Gruber J. . 2009 . Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program . National Bureau of Economic Research (NBER...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 835–851.
Published: 01 December 2022
... this incentive, policy makers should consider excluding PBM rebates from the calculation of AMP for 5i drugs. References CMS (Centers for Medicare and Medicaid Services) 2020 . “ Medicare Provider Utilization and Payment Data: Part D Prescriber .” https://www.cms.gov/Research-Statistics-Data-and-Systems...
FIGURES
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (2022) 47 (6): 779–796.
Published: 01 December 2022
... of Representatives suspected that the political environment could make it difficult for the secretary of Health and Human Services to extract significant price concessions from pharmaceutical companies on behalf of the Medicare program that would add materially to what Part D plans (PDPs) already negotiate...
Journal Article
J Health Polit Policy Law (2018) 43 (3): 543–546.
Published: 01 June 2018
... to those that shaped and eventually passed Medicare Part D. The Medicare Modernization Act of 2003 (MMA), championed by President George W. Bush, called for a new prescription drug addition to Medicare, which increased its budgetary ceiling by a proposed $400 billion over the first ten years. Like CLASS...
Journal Article
J Health Polit Policy Law (2014) 39 (2): 467–482.
Published: 01 April 2014
... of Medicare beneficiaries were in such plans. By 2013, over one in four Medicare beneficiaries (28 percent) had enrolled in a private insurance plan under Medicare Advantage, and enrollment growth continued apace despite cuts to plan payments under the Affordable Care Act. Further, Medicare's Part D benefit...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 731–753.
Published: 01 December 2022
...), and the PBM pays the pharmacy (arrow 6). In some cases the manufacturer seeks to eliminate patients' worries about cost sharing, and the effects of unfavorable formulary placement, by reimbursing part of that cost through copay coupons, although coupons are not allowed with Medicare Part D coverage (arrow 8...
FIGURES
Journal Article
J Health Polit Policy Law (2008) 33 (6): 1079–1106.
Published: 01 December 2008
... ): 115 -128. Frank, R., and J. Newhouse. 2008 . Should Drug Prices Be Negotiated under Part D of Medicare? And If So, How? Health Affairs 27 : 33 -43. Frederick, J. 2004 . Amid Challenges, Drug Chains Stand Their Ground. Drug Store News , August 23 . Freking, K. 2006 . Medicare...
Journal Article
J Health Polit Policy Law (2010) 35 (6): 845–848.
Published: 01 December 2010
..., focus on the Medicare Part D program, first implemented in 2006, under which beneficiaries can receive prescription drug coverage either through a managed care plan or a prescription drug – only health plan. Despite initial concern that there would be too few participating health plans...
Journal Article
J Health Polit Policy Law (2020) 45 (4): 501–515.
Published: 01 August 2020
... informed the design of the Medicare supplemental market, including Medicare Advantage, Medigap, and the Medicare Part D market. Beyond insurance, an equally futile market bureaucracy grew from consumer-driven approaches to medical care choices. There regulatory scaffolding supports policies attempting...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 629–648.
Published: 01 December 2022
... of Medicare Part D on Pharmaceutical Research and Development .” Journal of Public Economics 97 : 327 – 36 . CMS (Centers for Medicare and Medicaid Services) . 2021 . “ National Health Expenditures by Type of Service and Source of Funds, CY 1960–2020 .” December 15 . https://www.cms.gov...
FIGURES | View All (4)
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (2022) 47 (6): 815–833.
Published: 01 December 2022
... . 2020 . “ Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D .” National Bureau of Economic Research, NBER Working Paper No. 26751, February. https://doi.org/10.3386/w26751 . CMS (Centers for Medicare and Medicaid Services). n.d. “ The Facts about Open Payments Data: 2019...
Journal Article
J Health Polit Policy Law (2007) 32 (1): 1–7.
Published: 01 February 2007
... an element of hype — perhaps well intentioned, but hype nonetheless (Oliver 2006). And where the truth ends and the hype begins remains a bit obscure. Doughnut holes in Medicare: what more needs to be said? Clemens would certainly have been unsurprised to find that Medicare Part D was in large...